Physician

Bryan Schwent, M.D.

According to 2025 Medicare claims, Bryan Schwent, M.D. (NPI: 1760494835) practices ophthalmology in the Richmond, VA market, with the plurality of this provider's patient population coming from Chesterfield, VA. This provider's primary affiliated billing organization is VIRGINIA EYE CONSULTANTS INC (NPI: 1992727820; TIN: 541150779) and primary practice location at 23235-1989.

Schwent's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,279 traditional Medicare patients, billed 33,991 HCPCS/CPT codes, and received $3,849,557 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 716 prescription claims across 174 beneficiaries totaling $20,708 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $1,089,175 to $3,849,557. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $13,314 and ending at $20,708. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$2.0M$4.0M2015 Medicare payment: $1,089,175 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,563,399 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,948,184 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $2,772,121 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $3,226,629 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $3,658,180 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $4,014,469 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $3,782,285 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $3,708,054 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $3,849,557 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20158377,594$1,089,175
20169248,968$1,563,399
20171,01610,067$1,948,184
20181,09312,371$2,772,121
20191,23014,091$3,226,629
20201,17114,191$3,658,180
20211,18915,270$4,014,469
20221,29514,718$3,782,285
20231,33317,579$3,708,054
20241,27933,991$3,849,557

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$19K$38K2015 Drug cost: $13,314 (USD; Tot_Drug_Cst)2016 Drug cost: $20,394 (USD; Tot_Drug_Cst)2017 Drug cost: $16,484 (USD; Tot_Drug_Cst)2018 Drug cost: $21,178 (USD; Tot_Drug_Cst)2019 Drug cost: $38,120 (USD; Tot_Drug_Cst)2020 Drug cost: $26,274 (USD; Tot_Drug_Cst)2021 Drug cost: $36,266 (USD; Tot_Drug_Cst)2022 Drug cost: $30,682 (USD; Tot_Drug_Cst)2023 Drug cost: $24,808 (USD; Tot_Drug_Cst)2024 Drug cost: $20,708 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201585362$13,314
2016108440$20,394
2017116442$16,484
2018136537$21,178
2019133522$38,120
2020143551$26,274
2021162656$36,266
2022170625$30,682
2023153585$24,808
2024174716$20,708

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg2573,720$657
67028Injection of drug into eye4572,604$102
92014Established patient complete exam of visual system1,0391,571$83
92134Imaging of retina8093,129$31
92250Photography of the retina617824$27

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate2889,663$11,230
Ketorolac TromethamineKetorolac Tromethamine2046,880$4,448
OfloxacinOfloxacin511,207$540
Timolol MaleateTimolol Maleate513,460$347
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat221,490$229

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Bryan Schwent, M.D.?

Tedicare shows public-source Medicare data for Bryan Schwent, M.D. (NPI 1760494835), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Bryan Schwent, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Bryan Schwent, M.D.?

Bryan Schwent, M.D. is linked to VIRGINIA EYE CONSULTANTS INC (billing NPI 1992727820) in the available physician profile data.

Does Bryan Schwent, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.